Table 1 Patient Characteristics
Characteristics | Overall N (%) | IM@Home N (%) | EUC N (%) |
|---|---|---|---|
Total | 200 (100.0) | 99 (49.5) | 101 (50.5) |
Gender | |||
Female | 181 (90.5) | 91 (91.9) | 90 (89.1) |
Male | 19 (9.5) | 8 (8.1) | 11 (10.9) |
Age, years (mean [standard deviation; SD]) | 59.9 (12.4) | 60.4 (12.6) | 59.4 (12.3) |
Race | |||
White | 155 (77.5) | 78 (78.8) | 77 (76.2) |
Black or African American | 18 (9.0) | 10 (10.1) | 8 (7.9) |
Asian | 15 (7.5) | 6 (6.1) | 9 (8.9) |
American Indian or Alaska Native | 1 (0.5) | 0 (0.0) | 1 (1.0) |
Multiracial | 9 (4.5) | 3 (3.0) | 6 (5.9) |
Patient declined to answer | 2 (1.0) | 2 (2.0) | 0 (0.0) |
Ethnicity | |||
Hispanic or Latino | 9 (4.5) | 5 (5.1) | 4 (4.0) |
Education | |||
College degree or higher | 141 (70.5) | 68 (68.7) | 73 (72.3) |
High school or some college | 34 (17.0) | 20 (20.2) | 14 (13.9) |
Not reported | 25 (12.5) | 11 (11.1) | 14 (13.9) |
Cancer type | |||
Breast | 73 (36.5) | 35 (35.4) | 38 (37.6) |
Thoracic | 49 (24.5) | 25 (25.3) | 24 (23.8) |
Gynecologic | 43 (21.5) | 22 (22.2) | 21 (20.8) |
Head & Neck | 25 (12.5) | 13 (13.1) | 12 (11.9) |
Melanoma | 10 (5.0) | 4 (4.0) | 6 (5.9) |
Cancer stage at baseline | |||
Stage 0 | 5 (2.5) | 2 (2.0) | 3 (3.0) |
Stage 1–3 | 120 (60.0) | 65 (65.7) | 55 (54.5) |
Stage 4 | 75 (37.5) | 32 (32.3) | 43 (42.6) |
Cancer treatment modality* | |||
Radiation | 94 (47.0) | 47 (47.5) | 47 (46.5) |
Chemotherapy | 78 (39.0) | 38 (38.4) | 40 (39.6) |
Immunotherapy | 35 (17.5) | 18 (18.2) | 17 (16.8) |
Targeted therapy | 89 (44.5) | 44 (44.4) | 45 (44.6) |
BFI fatigue severity score** (mean [SD]) at baseline | 4.7 (1.9) | 4.6 (1.9) | 4.9 (1.8) |
